ArticlePharmaceuticals (Basel, Switzerland)2021

Repurposing FDA Drug Compounds against Breast Cancer by Targeting EGFR/HER2.

Irving Balbuena-Rebolledo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.